What is FIZE Medical?
FIZE Medical is a medical technology company focused on enhancing fluid management for critically ill patients. Their proprietary FIZE kUO system offers real-time, automated monitoring capabilities designed to facilitate precision fluid management, enable early intervention, and ultimately improve patient outcomes. The company is committed to driving innovation in this critical area, leveraging AI-driven insights and robust clinical evidence to set new standards in patient care.
How much funding has FIZE Medical raised?
FIZE Medical has raised a total of $39.3M across 2 funding rounds:
Series A
$9.3M
Series A
$30M
Series A (2021): $9.3M with participation from Mendham Investment Group and Rapha Capital Management
Series A (2025): $30M led by Rapha Capital Management, eHealth Ventures, and Valitas Ventures
Key Investors in FIZE Medical
Mendham Investment Group
Mendham Investment Group is an investment firm that likely focuses on strategic capital allocation within the healthcare and technology sectors, supporting companies with innovative solutions.
Rapha Capital Management
Rapha Capital Management, LLC specializes in identifying and investing in innovative biopharmaceutical companies and technologies that have the potential to significantly enhance healthcare and medicine. Established in mid-2018, the firm manages a diverse portfolio including companies such as Poseida Therapeutics and NexImmune. Their mission is to uncover disruptive ideas in the early stages of development that can lead to meaningful improvements in people's lives. Their intended clients include investors seeking opportunities in transformative healthcare advancements.
eHealth Ventures
eHealth Ventures is a consortium conceived to provide incubation services to promising early-stage healthcare technology companies in Israel. The Government of Israel offers a unique opportunity for leverage by providing significant financial incentives to incubators assisting technology start-ups capitalizing on Israel's extraordinarily rich talent pool. The next Tender is expected the second half of 2014. eHealth Ventures will apply for an eight-year license under the program. They are seeking qualified individual and institutional investors who would like to participate in this extraordinary, highly leveraged opportunity.
What's next for FIZE Medical?
With the recent influx of capital, FIZE Medical is poised for accelerated expansion and further development of its groundbreaking technology. The enterprise-level funding suggests a strategic focus on scaling operations, enhancing market penetration, and potentially exploring new applications for its fluid management solutions. This investment will likely fuel research and development initiatives, strengthen clinical partnerships, and support the company's mission to become a leader in precision fluid management for critical care settings.
See full FIZE Medical company page
